Last reviewed · How we verify

NCT06165926

Hypertonic Dextrose Injection and Physical Therapy for Frozen Shoulder

Status unknown NA Last updated 12 December 2023
What this trial tests

NA trial testing 15% hypertonic dextrose in Frozen Shoulder in 60 participants. Status unknown.

Timeline
1 January 2024
Primary endpoint
30 December 2024
31 December 2024

Quick facts

Lead sponsorTri-Service General Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date1 January 2024
Primary completion30 December 2024
Estimated completion31 December 2024

Drugs / interventions tested

Conditions studied

Sponsor

Tri-Service General Hospital

Who can join

Adults 30 to 70, any sex, with Frozen Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to investigate whether the combination of hypertonic dextrose injection and shoulder joint hydrodilation, in conjunction with physical therapy, can effectively enhance shoulder joint pain relief, improve range of motion, and enhance daily life functionality in patients with frozen shoulder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Frozen Shoulder

Currently open trials in the same condition.

Other Tri-Service General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06165926.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing